Professor Sir Jonathan Montgomery has been appointed as the chair of the expert group to advise on the Government’s response to the Infected Blood Inquiry’s recommendations on compensation. The names of the other members of the expert group have not been disclosed to safeguard the privacy and ability of experts to continue their frontline clinical roles whilst advising on Government policy.

The Government has committed to update Parliament through an oral statement on next steps within 25 sitting days following the publication of the final report on 20 May, and it is our intention to make this statement as soon as possible. Additionally, we will bring forward amendments at Report Stage of the Victims and Prisoners Bill in the Other Place with the intention of speeding up the implementation of the Government’s response to the Infected Blood Inquiry.

Our Mayors play a powerful role in driving economic growth, improving public services and giving local areas a powerful voice on the national stage. I met all the Mayors as a group before Christmas, as well as Mayor Brabin, as chair of UK Mayors this year, and a number of Mayors on an individual basis. I look forward to meeting and working closely with all the Mayors, collectively and individually, after the May elections, including the three new Mayors who will be elected for the East Midlands, the North-East Combined Authority, and York and North Yorkshire.

The Government will respond in full to Sir Brian Langstaff’s recommendations on compensation following the publication of the Inquiry’s final report on 20th May, and we will provide an update to Parliament on next steps within 25 sitting days following this date. Additionally, we will bring forward amendments at Report Stage of the Victims and Prisoners Bill in the Other Place with the intention of speeding up the implementation of the Government’s response to the Infected Blood Inquiry.

The Cabinet Office holds no information in relation to the Inquiry's methodology. The process and findings of the independent inquiry are a matter for the Chair, Sir Brian Langstaff.

The Government will raise the point at which child benefit is fully withdrawn to £80,000 from £60,000, and we will raise the high-income child benefit charge threshold to £60,000 from £50,000 from 6 April 2024, taking 170,000 families out of paying the charge. Overall, these changes mean that almost half a million hard-working families will gain an average of £1,260 towards the cost of raising their children.

The civil nuclear road map reconfirmed the Government’s ambition to deploy up to 24 GW of nuclear power by 2050. It sets out plans to make investment decisions about 3 GW to 7 GW every five years between 2030 and 2044.

Smoking is the number one entirely preventable cause of ill-health, disability and death in this country. It is responsible for 80,000 yearly deaths in the United Kingdom and one in four of all UK cancer deaths. It costs our country £17 billion a year, £14 billion of which is through lost productivity alone. It puts huge pressure on the National Health Service and social care, costing over £3 billion a year.

This is why the Government is planning to create a smokefree generation by bringing forward legislation so that children turning 15 years old this year or younger, will never be legally sold tobacco products.

Since this announcement, officials have undertaken a series of discussions with retailers and most recently met with the British Independent Retailers Association, the Association of Convenience Stores, and other trade associations to discuss the smokefree generation and youth vaping policy. We will continue to engage with the retail sector and ensure they are supported to implement future legislation.

Smoking is the number one entirely preventable cause of ill-health, disability and death in this country. It is responsible for 80,000 deaths in the United Kingdom a year, and one in four of all UK cancer deaths. It costs our country £17 billion a year, £14 billion of which is through lost productivity alone. It puts huge pressure on the National Health Service and social care, costing over £3 billion a year.

The Government response to the consultation entitled Creating a smokefree generation and tackling youth vaping, was published on 29 January 2024. The consultation received nearly 28,000 responses. Whilst there are no plans to publish the names of all the organisations that responded, we did confirm that we received responses from 896 organisations as well as 307 responses from those who disclosed links with the tobacco industry.

As outlined in our consultation response, the UK is a party to the WHO Framework Convention on Tobacco Control and so had an obligation to protect public health policy from the vested interests of the tobacco industry. In the consultation response we summarise the views of respondents with disclosed links to the tobacco industry but have been clear that we have not considered these views when determining our policy response.

Smoking is the number one entirely preventable cause of ill-health, disability and death in this country. It is responsible for 80,000 deaths in the United Kingdom a year, and one in four of all UK cancer deaths. It costs our country £17 billion a year, £14 billion of which is through lost productivity alone. It puts huge pressure on the National Health Service and social care, costing over £3 billion a year.

The Government response to the consultation entitled Creating a smokefree generation and tackling youth vaping, was published on 29 January 2024. The consultation received nearly 28,000 responses. Whilst there are no plans to publish the names of all the organisations that responded, we did confirm that we received responses from 896 organisations as well as 307 responses from those who disclosed links with the tobacco industry.

As outlined in our consultation response, the UK is a party to the WHO Framework Convention on Tobacco Control and so had an obligation to protect public health policy from the vested interests of the tobacco industry. In the consultation response we summarise the views of respondents with disclosed links to the tobacco industry but have been clear that we have not considered these views when determining our policy response.

The Ministry of Justice publishes information on the number of convictions for criminal offences, however to identify offenders that were ‘Libyan armed forces personnel trained at Bassingbourn barracks’ would require examination of individual court records, which would be of disproportionate costs.

The Government’s Life Sciences Vision sets out our ambition to develop a globally competitive life sciences investment ecosystem in the United Kingdom. While no assessment has been made, the 2024 voluntary scheme for branded medicines pricing, access and growth includes several policies that will benefit innovative companies and drive innovation into the United Kingdom. This includes an exemption from payment for small companies with under £6m of sales to the National Health Service and a taper for medium sized companies with between £6 million and £30 million of sales.

Commitments in the current voluntary scheme for branded medicines pricing and access around patient access and uptake for innovative medicines have had a substantial positive impact on the speed of medicines access in England, ensuring that National Health Service patients benefit from cutting-edge treatments including personalised CAR-T cancer therapies, lifechanging treatments for rare conditions, and lifesaving gene therapies. The new voluntary scheme for branded medicines pricing, access and growth agreement will continue to build on these significant achievements, for example, through the piloting of new approaches for paying for ground-breaking advanced therapy medicinal products.

We do not expect disproportional impacts on people with less common conditions resulting from these policies. Provisions in the scheme allow for companies to apply for price increases should supply of products be otherwise uneconomical. Under specific circumstances an adjusted ‘Top-up Payment Percentage’ can also be considered for other older medicines where there would otherwise be a negative impact on patients.

Commitments in the current voluntary scheme for branded medicines pricing and access around patient access and uptake for innovative medicines have had a substantial positive impact on the speed of medicines access in England, ensuring that National Health Service patients benefit from cutting-edge treatments including personalised CAR-T cancer therapies, lifechanging treatments for rare conditions, and lifesaving gene therapies. The new voluntary scheme for branded medicines pricing, access and growth agreement will continue to build on these significant achievements, for example, through the piloting of new approaches for paying for ground-breaking advanced therapy medicinal products.

We do not expect disproportional impacts on people with less common conditions resulting from these policies. Provisions in the scheme allow for companies to apply for price increases should supply of products be otherwise uneconomical. Under specific circumstances an adjusted ‘Top-up Payment Percentage’ can also be considered for other older medicines where there would otherwise be a negative impact on patients.

The Government has supported the uptake of low carbon fuels for 15 years through its Renewable Transport Fuel Obligation (RTFO) scheme. The RTFO sets targets for the supply of low carbon fuels and sustainability criteria, which these fuels must meet. The RTFO has been highly successful in securing a market for the supply of low carbon liquid fuels in the UK.

Under current carbon budgets, low carbon fuels contribute a third of greenhouse gas (GHG) savings in the domestic transport sector. In 2022, low carbon fuel that were reported under the RTFO saved on average 82 per cent carbon emissions compared to the fossil fuels that they replaced, saving 7.2 million tonnes of CO₂ emissions. In 2022, low carbon fuel made up 6.8 per cent of total road fuel supplied.

The Department plans to introduce a Sustainable Aviation Fuel (SAF) mandate from 2025, which will require at least ten per cent of UK aviation fuel to be made from sustainable sources from 2030. The Jet Zero Strategy set out that the use of SAF could contribute up to 17% of the emissions savings needed in the aviation sector by 2050.

The Department has accelerated the uptake of advanced low carbon fuels by allocating £171 million to advanced fuel demonstration projects through four competitions and is setting up a UK SAF Clearing House to support the testing and approval of advanced fuels for aviation.

The Department will also publish a Low Carbon Fuels Strategy to further support investment by setting out a vision for the deployment of low carbon fuels across transport modes up to 2050.

The Government has supported the uptake of low carbon fuels for 15 years through its Renewable Transport Fuel Obligation (RTFO) scheme. The RTFO sets targets for the supply of low carbon fuels and sustainability criteria, which these fuels must meet. The RTFO has been highly successful in securing a market for the supply of low carbon liquid fuels in the UK.

Under current carbon budgets, low carbon fuels contribute a third of greenhouse gas (GHG) savings in the domestic transport sector. In 2022, low carbon fuel that were reported under the RTFO saved on average 82 per cent carbon emissions compared to the fossil fuels that they replaced, saving 7.2 million tonnes of CO₂ emissions. In 2022, low carbon fuel made up 6.8 per cent of total road fuel supplied.

The Department plans to introduce a Sustainable Aviation Fuel (SAF) mandate from 2025, which will require at least ten per cent of UK aviation fuel to be made from sustainable sources from 2030. The Jet Zero Strategy set out that the use of SAF could contribute up to 17% of the emissions savings needed in the aviation sector by 2050.

The Department has accelerated the uptake of advanced low carbon fuels by allocating £171 million to advanced fuel demonstration projects through four competitions and is setting up a UK SAF Clearing House to support the testing and approval of advanced fuels for aviation.

The Department will also publish a Low Carbon Fuels Strategy to further support investment by setting out a vision for the deployment of low carbon fuels across transport modes up to 2050.